Overview
To compare clinical and molecular effects of nutritional support (immunonutrition or EPA-DHA enriched oral nutritional supplements) in patients with cancer undergoing surgery.
Eligibility
Inclusion Criteria:
- Patients with cancer undergoing surgery (primary tumor location; gastrointestinal tract, ovarian, peritoneal carcinomatosis)
Exclusion Criteria:
- End-stage liver disease
- End-stage kidney disease


